Search Results - "Caballero Barrigón, Maria Dolores"

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study by van Imhoff, Gustaaf W, McMillan, Andrew, Matasar, Matthew J, Radford, John, Ardeshna, Kirit M, Kuliczkowski, Kazimierz, Kim, WonSeog, Hong, Xiaonan, Goerloev, Jette Soenderskov, Davies, Andrew, Barrigón, María Dolores Caballero, Ogura, Michinori, Leppä, Sirpa, Fennessy, Michael, Liao, Qiming, van der Holt, Bronno, Lisby, Steen, Hagenbeek, Anton

“…Purpose We compared the efficacy of ofatumumab (O) versus rituximab (R) in combination with cisplatin, cytarabine, and dexamethasone (DHAP) salvage treatment,…”
Get full text

Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review by Hidalgo Calleja, Cristina, Martín Hidalgo, Daniel, Román Curto, Concepción, Vázquez López, Lourdes, Pérez López, Estefanía, Cabrero Calvo, Mónica, Martín López, Ana África, Caballero Barrigón, María Dolores, Lopez-Corral, Lucía

“…Abstract Background Chronic graft versus host disease (cGVHD) simulating eosinophilic fasciitis (EF) is an underdiagnosed and challenging complication due to…”
Get full text

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study by Younes, Anas, Brody, Joshua, Carpio, Cecilia, Lopez-Guillermo, Armando, Ben-Yehuda, Dina, Ferhanoglu, Burhan, Nagler, Arnon, Ozcan, Muhit, Avivi, Irit, Bosch, Francesc, Caballero Barrigón, Maria Dolores, Hellmann, Andrzej, Kuss, Bryone, Ma, David D F, Demirkan, Fatih, Yağci, Münci, Horowitz, Netanel A, Marlton, Paula, Cordoba, Raul, Wrobel, Tomasz, Buglio, Daniela, Streit, Michael, Hodkinson, Brendan P, Schaffer, Michael, Alvarez, John, Ceulemans, Rob, Balasubramanian, Sriram, de Jong, Jan, Wang, Shean-Sheng, Fourneau, Nele, Jurczak, Wojciech

“…Preclinical studies have shown synergistic antitumour effects between ibrutinib and immune-checkpoint blockade. The aim of this study was to assess the safety…”
Get full text

Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma by Alonso-Álvarez, Sara, Manni, Martina, Montoto, Silvia, Sarkozy, Clémentine, Morschhauser, Franck, Wondergem, Marielle J., Guarini, Attilio, Magnano, Laura, Alcoceba, Miguel, Chamuleau, Martine, Galimberti, Sara, Gomes da Silva, Maria, Holte, Harald, Zucca, Emanuele, Lockmer, Sandra, Aurer, Igor, Marcheselli, Luigi, Stepanishyna, Yana, Caballero Barrigón, María Dolores, Salles, Gilles, Federico, Massimo

“…Primary refractory (PREF) follicular lymphoma (FL) has a completely different clinical course from that of FL that responds to front-line treatments. In…”
Get full text

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis by Federico, Massimo, Caballero Barrigón, María Dolores, Marcheselli, Luigi, Tarantino, Vittoria, Manni, Martina, Sarkozy, Clementine, Alonso-Álvarez, Sara, Wondergem, Marielle, Cartron, Guillaume, Lopez-Guillermo, Armando, Issa, Djamila, Morschhauser, Franck, Alcoceba, Miguel, Kimby, Eva, Rusconi, Chiara, Chamuleau, Martine, Holte, Harald, Lockmer, Sandra, Montoto, Silvia, Gomes da Silva, Maria, Aurer, Igor, Zucca, Emanuele, Paszkiewicz-Kozik, Ewa, Minoia, Carla, Skrypets, Tetiana, Blaker, Yngvild Nuvin, Salles, Gilles, Coiffier, Bertrand

“…Histological transformation of follicular lymphoma to aggressive lymphoma is a serious event with a substantial effect on patient outcome. The aim of the…”
Get full text

New modalities in hematopoietic stem cell transplant by Caballero Barrigón, María Dolores

Get more information

Poster: CT-195 Predictive Value of ST2, REG3a, and MAGIC Algorithm in Haploidentical Transplantation With Post-Transplant Cyclophosphamide Outcomes by Santos, Marta Fonseca, Alvarez, Maria Garcia, Sanchez, Luis Antonio Corchete, Sanchez, Alberto Hernandez, Martinez, Borja Puertas, Salinero, Manuela, Rodriguez, Angela, Martin, Ana Africa, Pita, Alejandro Avendaño, Gonzalez, Monica Baile, Cabero, Almudena, Lopez, Estefania Perez, Calvo, Monica Cabrero, Sanchez-Guijo, Fermin, Lopez, Lourdes Vazquez, Garcia-Sanz, Ramon, Barrigon, Maria Dolores Caballero, Alcoceba, Miguel, Lopez-Corral, Lucia

Get full text

CT-195 Predictive Value of ST2, REG3a, and MAGIC Algorithm in Haploidentical Transplantation With Post-Transplant Cyclophosphamide Outcomes by Santos, Marta Fonseca, Alvarez, Maria Garcia, Sanchez, Luis Antonio Corchete, Sanchez, Alberto Hernandez, Martinez, Borja Puertas, Salinero, Manuela, Rodriguez, Angela, Martin, Ana Africa, Pita, Alejandro Avendaño, Gonzalez, Monica Baile, Cabero, Almudena, Lopez, Estefania Perez, Calvo, Monica Cabrero, Sanchez-Guijo, Fermin, Lopez, Lourdes Vazquez, Garcia-Sanz, Ramon, Barrigon, Maria Dolores Caballero, Alcoceba, Miguel, Lopez-Corral, Lucia, de Hematología, Servicio

Get full text

Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia by Younes, Anas, Brody, Joshua, Carpio, Cecilia, Lopez-Guillermo, Armando, Ben-Yehuda, Dina, Ferhanoglu, A. Burhan, Nagler, Arnon, Ozcan, Muhit, Avivi, Irit, Bosch Albareda, Francesc, Caballero Barrigón, María Dolores, Masood, Aisha, Streit, Michael, Alvarez, John, Ceulemans, Rob, Kharabi Masouleh, Behzad, Balasubramanian, Sriram, Schaffer, Michael, Wang, Shean-Sheng, Fourneau, Nele, Jurczak, Wojciech

“…Background: Preclinical studies have demonstrated synergistic antitumor activity when immune checkpoint inhibitors targeting the programmed cell death…”
Get full text

Response-Adapted Treatment with Rituximab/Bendamustine/Mitoxantrone/Dexamethasone and Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. RBMDGELTAMO08 Trial by Peñalver Párraga, Francisco Javier, Márquez Navarro, José Antonio, Durán Nieto, Soledad, Giraldo Castellano, Pilar, Montalbán Sanz, Carlos, Ramírez Sánchez, María José, Sancho Cia, Juan-Manuel, Terol Castera, María José, Capote Huelva, Francisco Javier, Gutiérrez García, Antonio, Sánchez González, Blanca, Salar Silvestre, Antonio, Canales Albendea, Miguel, Caballero Barrigón, María Dolores

“…Objectives: To evaluate the efficacy and toxicity of a response-adapted therapy with rituximab/bendamustine/mitoxantrone/dexamethasone (RBMD), followed by…”
Get full text

IBCL-176: Single-Centre Experience with Stem-Cell Transplantation in Patients with Transformed Lymphoma: A Potential Curative Option by Bua, Beatriz Rey, Santos, Marta Fonseca, Melchor, Raúl Azibeiro, Molano, Luz Gema Román, Mendoza, Danylo Palomino, Muñoz, Andres Felipe Peña, Úbeda, Sandra Patricia Gomez, Martinez, Borja Puertas, Sánchez, Alberto Hernández, Garcia, Laura Prieto, López, Estefania Pérez, Corral, Lucía López, Rodriguez, Maria Cortés, Sánchez-Guijo, Fermín, López, Ana Africa Martín, González, Mónica Baile, Parra, Miriam López, Alcoceba, Miguel, Alonso, Pilar Tamayo, Múñez, Óscar Blanco, Gutiérrez, Norma Carmen Gutiérrez, López, Lourdes Vazquez, Calvo, Mónica Cabrero, Barrigón, María Dolores Caballero, García-Sancho, Alejandro Martín

“…Outcomes of patients with transformed lymphoma have historically been poor, prompting many centres to include stem-cell transplant (SCT) as part of the…”
Get full text

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The Orcharrd Study (OMB110928) by van Imhoff, Gustaaf W, McMillan, Andrew, Matasar, Matthew J., Radford, John, Ardeshna, Kirit M, Kuliczkowski, Kazimierz, Kim, WonSeog, Hong, Xiaonan, Soenderskov Goerloev, Jette, Davies, Andrew, Caballero Barrigón, María Dolores, Ogura, Michinori, Fennessy, Michael, Liao, Qiming, van der Holt, Bronno, Lisby, Steen, Lin, Thomas S., Hagenbeek, Anton

“…Background: Salvage chemoimmunotherapy, followed by high-dose therapy and autologous stem cell transplantation (ASCT) for responding patients, is standard…”
Get full text

The Role of Hypomethylating Agents (Hma) in Early Myeloid Relapses After Allogenic Hematopoietic Stem Cell Transplant (HSCT) by Cadenas, Félix López, López, Ana Martín, Checa, Javier Carrillo, Godino, Oriana López, Ferré, Oscar, Martín, Luís García, López, Estefanía Pérez, López, Lourdes Vázquez, Díez-Campelo, María, Corral, Lucía López, Del Cañizo Fernández Roldán, Maria Consuelo, Caballero Barrigón, María Dolores, Calvo, Mónica Cabrero

Get full text

ZUMA-7: A phase 3 randomized trial of axicabtagene ciloleucel (Axi-Cel) versus standard-of-care (SOC) therapy in patients with relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) by Oluwole, Olalekan O., Bishop, Michael Russell, Gisselbrecht, Christian, Gordon, Leo I., Kersten, Marie Jose, Maloney, David G., Schmitz, Norbert, Caballero Barrigon, María Dolores, Kuruvilla, John, Song, Kevin W., Jacobson, Caron A., Nastoupil, Loretta J., Riedell, Peter, Jiang, Yizhou, Rossi, John M., Lee, Lillian, Cheng, Paul C., Locke, Frederick Lundry

“…Abstract only…”
Get full text

Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype by Garcia-Sanz, R, Vargas Montero, M, Gonzalez Diaz, M, del Carmen, M, Santos, C, Balanzategui Echevarria, A, Flores Corral, T, Hernandez Martin, JM, Caballero Barrigon, MD, San Miguel, JF

“…Department of Hematology, Hospital Universitario De Salamanca, Spain. BACKGROUND AND OBJECTIVE: Molecular genetic abnormalities have been frequently described…”
Get full text